Erdal Belen1, Aylin Sungur2, Mustafa Azmi Sungur2. 1. a Department of Cardiology , Okmeydanı Training and Research Hospital , Istanbul , Turkey ; 2. b Department of Cardiology , Kahramanmaras Necip Fazıl City Hospital , Kahramanmaras , Turkey.
Abstract
OBJECTIVES: Low levels of vitamin D are closely associated with cardiovascular diseases. Heart failure (HF) is a major health problem globally, occurring with increasing frequency and characterised by poor prognosis despite therapy. We aimed to investigate the effect of vitamin D levels on hospitalisation and mortality in patients with HF. DESIGN: Patients with ejection fraction <50% (n = 219) were included in this prospective study. Demographic, clinical and laboratory parameters were obtained at presentation. Patients were classified into Group 1 (vitamin D level ≤50 nmol/L) and Group 2 (vitamin D level >50 nmol/L). Median follow-up time was 12 months. Hospitalisation rates and overall survival were compared between groups. Independent predictors of hospitalisation and mortality were defined. RESULTS: With a median follow-up period of 12 months, hospitalisation and overall death occurred more frequently in Group 1 than in Group 2 (23.4% vs 7.3% and 16.1% vs 1.2%, respectively; p < 0.005 for both).Vitamin D was defined as an independent predictor of hospitalisation and mortality.Higher levels were found to be associated with decreased hospitalisation (HR 0.89, 95% CI 0.84-0.95, p < 0.001) and mortality (HR 0.83, 95% CI 0.75-0.92, p < 0.001). CONCLUSIONS: Vitamin D deficiency is highly prevalent in patients with HF, and low vitamin D levels are closely associated with increased hospitalisation and mortality.
OBJECTIVES: Low levels of vitamin D are closely associated with cardiovascular diseases. Heart failure (HF) is a major health problem globally, occurring with increasing frequency and characterised by poor prognosis despite therapy. We aimed to investigate the effect of vitamin D levels on hospitalisation and mortality in patients with HF. DESIGN:Patients with ejection fraction <50% (n = 219) were included in this prospective study. Demographic, clinical and laboratory parameters were obtained at presentation. Patients were classified into Group 1 (vitamin D level ≤50 nmol/L) and Group 2 (vitamin D level >50 nmol/L). Median follow-up time was 12 months. Hospitalisation rates and overall survival were compared between groups. Independent predictors of hospitalisation and mortality were defined. RESULTS: With a median follow-up period of 12 months, hospitalisation and overall death occurred more frequently in Group 1 than in Group 2 (23.4% vs 7.3% and 16.1% vs 1.2%, respectively; p < 0.005 for both).Vitamin D was defined as an independent predictor of hospitalisation and mortality.Higher levels were found to be associated with decreased hospitalisation (HR 0.89, 95% CI 0.84-0.95, p < 0.001) and mortality (HR 0.83, 95% CI 0.75-0.92, p < 0.001). CONCLUSIONS:Vitamin D deficiency is highly prevalent in patients with HF, and low vitamin D levels are closely associated with increased hospitalisation and mortality.
Entities:
Keywords:
follow-up studies; heart failure; hospitalisation; mortality; prognosis; vitamin D
Authors: A Separham; L Pourafkari; B Kazemi; Y Haghizadeh; F Akbarzadeh; M Toufan; H Sate; N D Nader Journal: Herz Date: 2017-10-09 Impact factor: 1.443
Authors: Richard M Cubbon; Judith E Lowry; Michael Drozd; Marlous Hall; John Gierula; Maria F Paton; Rowena Byrom; Lorraine C Kearney; Julian H Barth; Mark T Kearney; Klaus K Witte Journal: Eur J Nutr Date: 2018-08-18 Impact factor: 5.614
Authors: Daniel N Roffe-Vazquez; Anna S Huerta-Delgado; Elena C Castillo; José R Villarreal-Calderón; Adrian M Gonzalez-Gil; Cecilio Enriquez; Gerardo Garcia-Rivas; Leticia Elizondo-Montemayor Journal: Int J Mol Sci Date: 2019-11-19 Impact factor: 5.923